Clinical Trial Results:
A Randomized, Double-Blind, Phase II Trial of CT-322 (BMS-844203) plus Irinotecan,
5-FU and Leucovorin (FOLFIRI) versus Bevacizumab plus FOLFIRI as Second-Line
Treatment for Metastatic Colorectal Cancer
Summary
|
|
EudraCT number |
2008-006561-89 |
Trial protocol |
FR IT |
Global completion date |
17 Oct 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Dec 2016
|
First version publication date |
07 Dec 2016
|
Other versions |
|
Summary report(s) |
CA196-004_Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.